CSCO
64
3
PAYX
38
2
HPE
69
-2
KSS
36
3
OKE
46
-3
ADP
72
2
ICE
55
2
DVA
56
-3
O
33
-6
HON
65
-12
DTE
38
2
CA
18
-9
HBAN
65
-3
WEC
48
3
EXC
47
2
AES
46
12
BA
45
3
NKE
56
-2
GS
63
-2
VIX
40
-9
CSCO
64
3
PAYX
38
2
HPE
69
-2
KSS
36
3
OKE
46
-3
ADP
72
2
ICE
55
2
DVA
56
-3
O
33
-6
HON
65
-12
DTE
38
2
CA
18
-9
HBAN
65
-3
WEC
48
3
EXC
47
2
AES
46
12
BA
45
3
NKE
56
-2
GS
63
-2
VIX
40
-9
Financhill
Back

EverQuote Vs. Blueprint Medicines Industry Stock Comparison

Buy
78

EVER
EverQuote

Last Price:
$24.88
Seasonality Move:
-9.78%
Sell
49

BPMC
Blueprint Medicines

Last Price:
$128.57
Seasonality Move:
7.99%
Buy
78
EverQuote (EVER) is a Buy

Is EverQuote a Buy, Sell or Hold?

  • The current EverQuote [EVER] share price is $24.89. The Score for EVER is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • EVER is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $128.55. The Score for BPMC is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EVER Stock Price Chart

What is EverQuote's stock price today?

  • The EverQuote share price today is $24.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EVER is experiencing slight buying pressure.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $128.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

EVER Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.5 Buy
Relative Strength Index (14 RSI): 56.06 Buy
Chaikin Money Flow: 123515 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.95 - 25.29) Buy
Bollinger Bands (100): (22.27 - 26.41) Buy

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.85 Buy
Relative Strength Index (14 RSI): 75.06 Buy
Chaikin Money Flow: 2214841 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (127.95 - 128.37) Buy
Bollinger Bands (100): (84.58 - 118.32) Buy

EVER Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.46 Buy
20-day SMA: 24.56 Buy
50-day SMA: 24.26 Buy
200-day SMA: 21.86 Buy
8-day EMA: 9.77 Buy
20-day EMA: 4.48 Buy
50-day EMA: 1.9 Buy
200-day EMA: 0.49 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.32 Buy
20-day SMA: 128.22 Buy
50-day SMA: 114.09 Buy
200-day SMA: 98.23 Buy
8-day EMA: 128.32 Buy
20-day EMA: 126.07 Buy
50-day EMA: 116.58 Buy
200-day EMA: 101.59 Buy

EverQuote Earnings Growth & EVER Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.24 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.

EverQuote Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):